Resveratrolia ei vaan ole testattu ihmisellä mitenkään eli sen vaikutuksia on paha sanoa.
AIJAA? Mikäs trolli sinä olet?
Resveratrol
exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. Runqing Lu1, Ginette Serrero1,2 Journal of cellular physiology, 1999
Resveratrol Acts as a Mixed Agonist/
Antagonist for Estrogen Receptors and ß1
Jennifer L. Bowers, Valentyn V. Tyulmenkov, Sarah C. Jernigan and Carolyn M. Klinge
Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, Kentucky 40292
Resveratrol-Induced Gene Expression Profiles in Human Prostate Cancer Cells
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 596 - 604.
Resveratrol Induces Growth Inhibition, S-phase Arrest, Apoptosis, and Changes in Biomarker Expression in Several Human Cancer Cell Lines. Clin. Cancer Res., March 1, 2002; 8(3): 893 - 903.
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Abdalla M. El-Mowafy1,3 and Moussa Alkhalaf. 2 Department of Biochemistry, Faculty of Medicine, Health Sciences Center, Kuwait University, PO Box 24923, Safat 13110, Kuwait
Baur JA, Sinclair DA (2006). "Therapeutic potential of resveratrol:
the in vivo evidence". Nat Rev Drug Discov 5 (6): 493–506. doi:10.1038/nrd2060. PMID 16732220.
"Resveratrol: a review of preclinical studies for
human cancer prevention". Toxicology and Applied Pharmacology 224 (3): 274–83. doi:10.1016/j.taap.2006.12.025. PMID 17306316.
"Phase I dose escalation pharmacokinetic study
in healthy volunteers of resveratrol, a potential cancer chemopreventive agent". Cancer Epidemiology, Biomarkers & Prevention 16 (6): 1246–52. doi:10.1158/1055-9965.EPI-07-0022. PMID 17548692.
Wade, Nicholas (November 16, 2006). "Red Wine Ingredient Increases Endurance, Study Shows". New York Times.
Lagouge M, Argmann C, Gerhart-Hines Z, et al. (December 2006). "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha". Cell 127 (6): 1109–22. doi:10.1016/j.cell.2006.11.013. PMID 17112576.
Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM (March 2002). "Effect of resveratrol on platelet aggregation
in vivo and in vitro". Chinese Medical Journal 115 (3): 378–80. PMID 11940369.
Deng, J.-Y.; Hsieh, P.-S.; Huang, J.-P.; Lu, L.-S.; Hung, L.-M. (2008). "Activation of Estrogen Receptor Is Crucial for Resveratrol-Stimulating Muscular Glucose Uptake via Both Insulin-Dependent and -Independent Pathways". Diabetes 57 (7): 1814. doi:10.2337/db07-1750. PMID 18426865.
Penumathsa SV, Thirunavukkarasu M, Zhan L, et al. (December 2008). "Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium". Journal of Cellular and Molecular Medicine 12 (6A): 2350–61. doi:10.1111/j.1582-4934.2008.00251.x. PMID 18266981.
Yu C, Shin YG, Chow A, et al. (December 2002). "
Human, rat, and mouse metabolism of resveratrol". Pharmaceutical Research 19 (12): 1907–14. doi:10.1023/A:1021414129280. PMID 12523673.
Wang LX, Heredia A, Song H, et al. (October 2004). "Resveratrol glucuronides as the metabolites of resveratrol
in humans: characterization, synthesis, and anti-HIV activity". Journal of Pharmaceutical Sciences 93 (10): 2448–57. doi:10.1002/jps.20156. PMID 15349955.
Vitaglione P, Sforza S, Galaverna G, et al. (May 2005). "Bioavailability of trans-resveratrol from red wine
in humans". Molecular Nutrition & Food Research 49 (5): 495–504. doi:10.1002/mnfr.200500002. PMID 15830336.
Gehm BD, McAndrews JM, Chien PY, Jameson JL (December 1997). "Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor". Proceedings of the National Academy of Sciences of the United States of America 94 (25): 14138–43. doi:10.1073/pnas.94.25.14138. PMID 9391166.
Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM (October 2000). "Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta". Endocrinology 141 (10): 3657–67. doi:10.1210/en.141.10.3657. PMID 11014220.
Stefani M, Markus MA, Lin RC, Pinese M, Dawes IW, Morris BJ (October 2007). "The effect of resveratrol on a cell model of human aging". Annals of the New York Academy of Sciences 1114: 407–18. doi:10.1196/annals.1396.001. PMID 17804521.
Chun YJ, Kim MY, Guengerich FP (August 1999). "Resveratrol is a selective
human cytochrome P450 1A1 inhibitor". Biochemical and Biophysical Research Communications 262 (1): 20–4. doi:10.1006/bbrc.1999.1152. PMID 10448061.
Schwarz D, Roots I (April 2003). "In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by
human CYP1A1". Biochemical and Biophysical Research Communications 303 (3): 902–7. doi:10.1016/S0006-291X(03)00435-2. PMID 12670496.
Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM (October 2001). "Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models". Cancer Research 61 (20): 7456–63. PMID 11606380.
Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C (March 2004). "
Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels". The Journal of Clinical Endocrinology and Metabolism 89 (3): 1174–80. doi:10.1210/jc.2003-031467. PMID 15001605.
Stewart JR, Artime MC, O'Brian CA (1 July 2003). "Resveratrol: a candidate nutritional substance for prostate cancer prevention". J